149 related articles for article (PubMed ID: 10360828)
1. Combined therapy with anti-P-glycoprotein antibody and macrophage colony-stimulating factor gene transduction for multiorgan metastases of multidrug-resistant human small cell lung cancer in NK cell-depleted SCID mice.
Yano S; Hanibuchi M; Nishioka Y; Nokihara H; Nishimura N; Tsuruo T; Sone S
Int J Cancer; 1999 Jul; 82(1):105-11. PubMed ID: 10360828
[TBL] [Abstract][Full Text] [Related]
2. Monocyte chemoattractant protein-1 gene modification of multidrug-resistant human lung cancer enhances antimetastatic effect of therapy with anti-P-glycoprotein antibody in SCID mice.
Nokihara H; Nishioka Y; Yano S; Mukaida N; Matsushima K; Tsuruo T; Sone S
Int J Cancer; 1999 Mar; 80(5):773-80. PubMed ID: 10048981
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of multiorgan metastases of human lung cancer cells genetically engineered to produce cytokines and reversal using chimeric monoclonal antibodies in natural killer cell-depleted severe combined immunodeficient mice.
Sone S; Yano S; Hanibuchi M; Nokihara H; Nishimura N; Miki T; Nishioka Y; Shinohara T
Cancer Chemother Pharmacol; 1999; 43 Suppl():S26-31. PubMed ID: 10357555
[TBL] [Abstract][Full Text] [Related]
4. A new quinoline derivative MS-209 reverses multidrug resistance and inhibits multiorgan metastases by P-glycoprotein-expressing human small cell lung cancer cells.
Nokihara H; Yano S; Nishioka Y; Hanibuchi M; Higasida T; Tsuruo T; Sone S
Jpn J Cancer Res; 2001 Jul; 92(7):785-92. PubMed ID: 11473730
[TBL] [Abstract][Full Text] [Related]
5. Combined therapy of multidrug-resistant human lung cancer with anti-P-glycoprotein antibody and monocyte chemoattractant protein-1 gene transduction: the possibility of immunological overcoming of multidrug resistance.
Nishioka Y; Yano S; Fujiki F; Mukaida N; Matsushima K; Tsuruo T; Sone S
Int J Cancer; 1997 Apr; 71(2):170-7. PubMed ID: 9139838
[TBL] [Abstract][Full Text] [Related]
6. Macrophage colony-stimulating factor gene transduction into human lung cancer cells differentially regulates metastasis formations in various organ microenvironments of natural killer cell-depleted SCID mice.
Yano S; Nishioka Y; Nokihara H; Sone S
Cancer Res; 1997 Feb; 57(4):784-90. PubMed ID: 9044861
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacy of mouse-human chimeric anti-ganglioside GM2 monoclonal antibody against multiple organ micrometastases of human lung cancer in NK cell-depleted SCID mice.
Hanibuchi M; Yano S; Nishioka Y; Yanagawa H; Kawano T; Sone S
Int J Cancer; 1998 Nov; 78(4):480-5. PubMed ID: 9797137
[TBL] [Abstract][Full Text] [Related]
8. Novel metastasis model of human lung cancer in SCID mice depleted of NK cells.
Yano S; Nishioka Y; Izumi K; Tsuruo T; Tanaka T; Miyasaka M; Sone S
Int J Cancer; 1996 Jul; 67(2):211-7. PubMed ID: 8760590
[TBL] [Abstract][Full Text] [Related]
9. Influence of systemic chemotherapy on anti-P-glycoprotein antibody-dependent cell-mediated cytotoxicity in patients with small cell lung cancer.
Nabioullin R; Yanagawa H; Haku T; Hiramatsu K; Yano S; Hanibuchi M; Pai K; Tsuruo T; Sone S
Jpn J Clin Oncol; 1995 Aug; 25(4):124-30. PubMed ID: 7666588
[TBL] [Abstract][Full Text] [Related]
10. Transduction of the macrophage colony-stimulating factor gene into human multidrug resistant cancer cells: enhanced therapeutic efficacy of monoclonal anti-P-glycoprotein antibody in nude mice.
Sone S; Tsuruo T; Sato S; Yano S; Nishioka Y; Shinohara T
Jpn J Cancer Res; 1996 Jul; 87(7):757-64. PubMed ID: 8698627
[TBL] [Abstract][Full Text] [Related]
11. M-CSF gene transduction in multidrug-resistant human cancer cells to enhance anti-P-glycoprotein antibody-dependent macrophage-mediated cytotoxicity.
Heike Y; Sone S; Yano S; Seimiya H; Tsuruo T; Ogura T
Int J Cancer; 1993 Jul; 54(5):851-7. PubMed ID: 8100809
[TBL] [Abstract][Full Text] [Related]
12. Bone metastasis model with multiorgan dissemination of human small-cell lung cancer (SBC-5) cells in natural killer cell-depleted SCID mice.
Miki T; Yano S; Hanibuchi M; Sone S
Oncol Res; 2000; 12(5):209-17. PubMed ID: 11417746
[TBL] [Abstract][Full Text] [Related]
13. Enhancement by recombinant human interferon alfa of the reversal of multidrug resistance by MRK-16 monoclonal antibody.
Fogler WE; Pearson JW; Volker K; Ariyoshi K; Watabe H; Riggs CW; Wiltrout RH; Longo DL
J Natl Cancer Inst; 1995 Jan; 87(2):94-104. PubMed ID: 7707396
[TBL] [Abstract][Full Text] [Related]
14. Effector cell analysis of human multidrug-resistant cell killing by mouse-human chimeric antibody against P-glycoprotein.
Nishioka Y; Sone S; Heike Y; Hamada H; Ariyoshi K; Tsuruo T; Ogura T
Jpn J Cancer Res; 1992 Jun; 83(6):644-9. PubMed ID: 1353755
[TBL] [Abstract][Full Text] [Related]
15. Neutrophils contribute to the biological antitumor activity of rituximab in a non-Hodgkin's lymphoma severe combined immunodeficiency mouse model.
Hernandez-Ilizaliturri FJ; Jupudy V; Ostberg J; Oflazoglu E; Huberman A; Repasky E; Czuczman MS
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5866-73. PubMed ID: 14676108
[TBL] [Abstract][Full Text] [Related]
16. Characterization of an etoposide-resistant human small-cell lung cancer cell line.
Minato K; Kanzawa F; Nishio K; Nakagawa K; Fujiwara Y; Saijo N
Cancer Chemother Pharmacol; 1990; 26(5):313-7. PubMed ID: 1976450
[TBL] [Abstract][Full Text] [Related]
17. P-glycoprotein-mediated multidrug resistance and lymphokine-activated killer cell susceptibility in ovarian carcinoma.
Savas B; Cole SP; Tsuruo T; Pross HF
J Clin Immunol; 1996 Nov; 16(6):348-57. PubMed ID: 8946280
[TBL] [Abstract][Full Text] [Related]
18. Tumor vaccination with macrophage colony-stimulating factor-producing Lewis lung carcinoma in mice.
Morita T; Ikeda K; Douzono M; Yamada M; Kimura F; Kawakami K; Sasaki K; Motoyoshi K; Takahara J; Irino S
Blood; 1996 Aug; 88(3):955-61. PubMed ID: 8704254
[TBL] [Abstract][Full Text] [Related]
19. Combined therapy with a new bisphosphonate, minodronate (YM529), and chemotherapy for multiple organ metastases of small cell lung cancer cells in severe combined immunodeficient mice.
Yano S; Zhang H; Hanibuchi M; Miki T; Goto H; Uehara H; Sone S
Clin Cancer Res; 2003 Nov; 9(14):5380-5. PubMed ID: 14614023
[TBL] [Abstract][Full Text] [Related]
20. Circumvention of multidrug resistance by a quinoline derivative, MS-209, in multidrug-resistant human small-cell lung cancer cells and its synergistic interaction with cyclosporin A or verapamil.
Shrivastava P; Hanibuchi M; Yano S; Parajuli P; Tsuruo T; Sone S
Cancer Chemother Pharmacol; 1998; 42(6):483-90. PubMed ID: 9788575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
